Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models

Journal of the National Cancer Institute

Volumn 92, Issue 2, 2000, Pages 143-147

  Li, Chuan Yuan ^a   Shan, Siqing ^a   Huang, Qian ^a   Braun, Rod D ^a   Lanzen, Jennifer ^a   Hu, Kang ^a   Lin, Pengnian ^a   Dewhirst, Mark W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CANCER STAGING; CHEMOTAXIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME;

EID: 0034684999     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.2.143     Document Type: Article

References (34)

1. Folkman J, Hanahan D. Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 1991;22:339-47.
2. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71.
3. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
4. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339:58-61.
5. Kandel J, Bossy-Wetzel E, Radveny F, Klagsbrun M, Folkman J, Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multi-stage development of fibrosarcoma. Cell 1991;66:1095-104.
6. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6.
7. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC. Green fluorescent protein as a marker for gene expression. Science 1994;263: 802-5.
8. Heim R, Tsien RY. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol 1996;6:178-82.
9. Prasher DC. Using GFP to see the light. Trends Genet 1995;11:320-3.
10. Algire GH, Legallais FY. Recent developments in the transparent chamber technique as adapted to the mouse. J Natl Cancer Inst 1949; 10:225-53.
11. Papenfuss HD, Gross JF, Intaglitta M, Teese FA. A transparent access chamber for the rat dorsal skinfold. Microvasc Res 1979;18:311-8.
12. Gross J, Roemer R, Dewhirst M, Meyer T. A uniform thermal field in a hyperthermia chamber for microvascular studies. Int J Heat Mass Transfer 1982;25:1313-20.
13. Dewhirst M, Gross J, Sim D, Arnold P, Boyer D. The effect of rate of heating and cooling prior to heating on tumor and normal tissue microcirculatory blood flow. Bioreheology 1984;21:539-58.
14. Hilf R, Michel I, Bell C, Freeman J, Borman A. Biochemical and morphological properties of a new lactating mammary tumor line in the rat. Cancer Res 1965;25:286-99.
15. Dexter DL, Kowalski HM, Blazer BA, Fligiel Z, Vogel R, Hepprer GH. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 1978;38:3174-81.
16. Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorescence protein (GFP). Gene 1996;173:33-8.
17. Zhang G, Gurtu V, Kain SR. An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem Biophys Res Commun 1996;227:707-11.
18. Dewhirst MW, Tso CY, Oliver R, Gustafson CS, Secomb TW, Gross JF. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int J Radiat Oncol Biol Biophys 1989;17:91-9.
19. Dewhirst MW, Ong ET, Klitzman B, Secomb TW, Vinuya RZ, Dodge R, et al. Perivascular oxygen tensions a transplantable mammary tumor growing in a dorsal flap window chamber. Radiat Res 1992;130:171-82.
20. Lin P, Sankar S, Shan SQ, Dewhirst MW, Polverini PJ, Quinn TQ. et al. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ 1998;9:49-58.
21. Talmadge JE, Wollman SR, Fidler IJ. Evidence for the clonal origin of spontaneous metastasis. Science 1982;217:361-3.
22. Talmadge JE, Zbar B. Clonality of pulmonary metastasis from the bladder: 6 sublines of the B16 melanoma studied by Southern hybridization. J Natl Cancer Inst. 1987;78:315-20.
23. Chambers AF, Wilson S. Use of NeoR B16F1 murine melanoma cells to access clonality of experimental metastases in the immune deficient chick embryo. Clin Exp Metastasis 1988; 6:171-82.
24. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res 1996;56:1615-20.
25. Boehm T, Folkman J, Browder T, O'Reiley MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997;390:404-7.
26. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Cao Y, et al. Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harbor Symp Quant Biol 1994;59: 471-82.
27. Holmgren L, O'Reiley MS, Folkman J. Dormancy of micrometastasis: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149-53.
28. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
29. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284:1994-8.
30. Folkman J. Tumor angiogenesis. In: Holland J, Frei E, Bast R, Kufe D, Morton D, Weichselbaum R, editors. Cancer medicine. Baltimore (MD): William & Wilkins; 1996. p. 181-204.
31. Nicosia RF, Tchao R, Leighton J. Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Res 1983;43:2159-66.
32. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. Lab Invest 1990;63:115-22.
33. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, et al. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 1994;54:4791-7.
34. Koop S, Schmidt EE, MacDonald IC, Morris VL, Khokha R, Grattan M, et al. Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci U S A 1996;93:11080-4.